Figures & data
Table 1 Baseline clinical and demographic characteristic of patients with type 2 diabetes mellitus initiated on exenatide bid or insulin therapy
Table 2 Mean daily dose of injectable therapy and the percentages of patients using oral antidiabetes drug medication
Table 3 Resource use in patients with type 2 diabetes mellitus receiving exenatide bid or insulin therapy by country
Figure 1 Mean number of health care professional contacts per 6 months by country during treatment with (A) exenatide bid or (B) insulin therapy in clinical practice.
Figure 2 Mean cost (€) per patient before and after initiation of exenatide bid or insulin in clinical practice.
Table 4 Mean direct medical cost (€) per patient receiving exenatide bid or insulin therapy in clinical practice
Table 5 Analysis of covariance for direct medical cost per patient per 6 months during treatment with exenatide bid or insulin in patients with type 2 diabetes mellitus